Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avexitide in post-bariatric hypoglycemia
NCT02771574Phase 2Completed
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of exendin 9-39 in Postprandial hyperinsulinemic hypoglycemia (PHH). Started May 2016; status: completed.
02
Drugs
exendin 9-39
03
Conditions
Postprandial hyperinsulinemic hypoglycemia (PHH)
Beyond the preview
Go deeper on NCT02771574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771574.